nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—TNF—acquired immunodeficiency syndrome	0.361	1	CbGaD
Chloroquine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0227	0.0468	CbGbCtD
Chloroquine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0205	0.0423	CbGbCtD
Chloroquine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0205	0.0423	CbGbCtD
Chloroquine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0197	0.0407	CbGbCtD
Chloroquine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0197	0.0407	CbGbCtD
Chloroquine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0177	0.0366	CbGbCtD
Chloroquine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0172	0.0355	CbGbCtD
Chloroquine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0155	0.0321	CbGbCtD
Chloroquine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0155	0.0321	CbGbCtD
Chloroquine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0149	0.0309	CbGbCtD
Chloroquine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0149	0.0309	CbGbCtD
Chloroquine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0148	0.0305	CbGbCtD
Chloroquine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0147	0.0305	CbGbCtD
Chloroquine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0143	0.0296	CbGbCtD
Chloroquine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0139	0.0287	CbGbCtD
Chloroquine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0139	0.0287	CbGbCtD
Chloroquine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0133	0.0276	CbGbCtD
Chloroquine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0126	0.026	CbGbCtD
Chloroquine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0126	0.026	CbGbCtD
Chloroquine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0115	0.0238	CbGbCtD
Chloroquine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0112	0.0231	CbGbCtD
Chloroquine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0108	0.0224	CbGbCtD
Chloroquine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0105	0.0218	CbGbCtD
Chloroquine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0101	0.0209	CbGbCtD
Chloroquine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0101	0.0209	CbGbCtD
Chloroquine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00969	0.02	CbGbCtD
Chloroquine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00953	0.0197	CbGbCtD
Chloroquine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00953	0.0197	CbGbCtD
Chloroquine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0094	0.0194	CbGbCtD
Chloroquine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00884	0.0183	CbGbCtD
Chloroquine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00884	0.0183	CbGbCtD
Chloroquine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00799	0.0165	CbGbCtD
Chloroquine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00799	0.0165	CbGbCtD
Chloroquine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0075	0.0155	CbGbCtD
Chloroquine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0069	0.0143	CbGbCtD
Chloroquine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0067	0.0138	CbGbCtD
Chloroquine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00606	0.0125	CbGbCtD
Chloroquine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00606	0.0125	CbGbCtD
Chloroquine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00581	0.012	CbGbCtD
Chloroquine—GSTA2—blood plasma—acquired immunodeficiency syndrome	0.00231	0.0976	CbGeAlD
Chloroquine—TNF—blood—acquired immunodeficiency syndrome	0.00195	0.0823	CbGeAlD
Chloroquine—TNF—vagina—acquired immunodeficiency syndrome	0.00181	0.0763	CbGeAlD
Chloroquine—TNF—EV release from cardiac cells and their functional effects—CXCL12—acquired immunodeficiency syndrome	0.00148	0.0599	CbGpPWpGaD
Chloroquine—TNF—lymph node—acquired immunodeficiency syndrome	0.00117	0.0493	CbGeAlD
Chloroquine—GSTA2—lymphoid tissue—acquired immunodeficiency syndrome	0.000901	0.038	CbGeAlD
Chloroquine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000894	0.0377	CbGeAlD
Chloroquine—GSTA2—digestive system—acquired immunodeficiency syndrome	0.00089	0.0375	CbGeAlD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL15—acquired immunodeficiency syndrome	0.000864	0.035	CbGpPWpGaD
Chloroquine—GSTA2—blood—acquired immunodeficiency syndrome	0.000848	0.0358	CbGeAlD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.000819	0.0332	CbGpPWpGaD
Chloroquine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000807	0.034	CbGeAlD
Chloroquine—GSTA2—lung—acquired immunodeficiency syndrome	0.000743	0.0313	CbGeAlD
Chloroquine—GSTA2—nervous system—acquired immunodeficiency syndrome	0.000688	0.029	CbGeAlD
Chloroquine—GSTA2—central nervous system—acquired immunodeficiency syndrome	0.000663	0.0279	CbGeAlD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.00064	0.0259	CbGpPWpGaD
Chloroquine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000606	0.0255	CbGeAlD
Chloroquine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000596	0.0251	CbGeAlD
Chloroquine—TNF—FAS pathway and Stress induction of HSP regulation—ACTG1—acquired immunodeficiency syndrome	0.000582	0.0236	CbGpPWpGaD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.00056	0.0227	CbGpPWpGaD
Chloroquine—GSTA2—brain—acquired immunodeficiency syndrome	0.000526	0.0222	CbGeAlD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.000504	0.0204	CbGpPWpGaD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.000456	0.0185	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.000437	0.0177	CbGpPWpGaD
Chloroquine—TNF—EBV LMP1 signaling—CCL5—acquired immunodeficiency syndrome	0.000434	0.0176	CbGpPWpGaD
Chloroquine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000429	0.0181	CbGeAlD
Chloroquine—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000397	0.0167	CbGeAlD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL10—acquired immunodeficiency syndrome	0.00038	0.0154	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—CSF2—acquired immunodeficiency syndrome	0.000376	0.0153	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL4—acquired immunodeficiency syndrome	0.00037	0.015	CbGpPWpGaD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000362	0.0147	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000356	0.0144	CbGpPWpGaD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000336	0.0136	CbGpPWpGaD
Chloroquine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000328	0.0138	CbGeAlD
Chloroquine—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000317	0.0134	CbGeAlD
Chloroquine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.00031	0.0131	CbGeAlD
Chloroquine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000304	0.0128	CbGeAlD
Chloroquine—CYP1A1—blood—acquired immunodeficiency syndrome	0.000302	0.0128	CbGeAlD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000299	0.0121	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.000298	0.0121	CbGpPWpGaD
Chloroquine—CYP3A5—blood—acquired immunodeficiency syndrome	0.000296	0.0125	CbGeAlD
Chloroquine—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000291	0.00272	CcSEcCtD
Chloroquine—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.0027	CcSEcCtD
Chloroquine—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.000287	0.00269	CcSEcCtD
Chloroquine—Hallucination—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00269	CcSEcCtD
Chloroquine—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.00268	CcSEcCtD
Chloroquine—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00267	CcSEcCtD
Chloroquine—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000285	0.00266	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.00265	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000283	0.0115	CbGpPWpGaD
Chloroquine—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.000282	0.00264	CcSEcCtD
Chloroquine—Tinnitus—Efavirenz—acquired immunodeficiency syndrome	0.000281	0.00263	CcSEcCtD
Chloroquine—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000281	0.00263	CcSEcCtD
Chloroquine—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00028	0.00262	CcSEcCtD
Chloroquine—CYP1A1—vagina—acquired immunodeficiency syndrome	0.00028	0.0118	CbGeAlD
Chloroquine—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000277	0.00259	CcSEcCtD
Chloroquine—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000277	0.00259	CcSEcCtD
Chloroquine—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000276	0.00258	CcSEcCtD
Chloroquine—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000275	0.00257	CcSEcCtD
Chloroquine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000274	0.0116	CbGeAlD
Chloroquine—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000273	0.00255	CcSEcCtD
Chloroquine—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.00255	CcSEcCtD
Chloroquine—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000271	0.00253	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.00253	CcSEcCtD
Chloroquine—Tinnitus—Delavirdine—acquired immunodeficiency syndrome	0.000269	0.00252	CcSEcCtD
Chloroquine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000268	0.00251	CcSEcCtD
Chloroquine—TNF—TWEAK Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000268	0.0109	CbGpPWpGaD
Chloroquine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000268	0.0025	CcSEcCtD
Chloroquine—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.0025	CcSEcCtD
Chloroquine—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000267	0.00249	CcSEcCtD
Chloroquine—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00248	CcSEcCtD
Chloroquine—CYP1A1—lung—acquired immunodeficiency syndrome	0.000265	0.0112	CbGeAlD
Chloroquine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000264	0.00247	CcSEcCtD
Chloroquine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000262	0.00245	CcSEcCtD
Chloroquine—CYP3A5—lung—acquired immunodeficiency syndrome	0.000259	0.0109	CbGeAlD
Chloroquine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000259	0.00242	CcSEcCtD
Chloroquine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000258	0.00242	CcSEcCtD
Chloroquine—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00241	CcSEcCtD
Chloroquine—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.0024	CcSEcCtD
Chloroquine—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00239	CcSEcCtD
Chloroquine—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000256	0.00239	CcSEcCtD
Chloroquine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00239	CcSEcCtD
Chloroquine—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000255	0.00239	CcSEcCtD
Chloroquine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.00238	CcSEcCtD
Chloroquine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000255	0.00238	CcSEcCtD
Chloroquine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000254	0.00238	CcSEcCtD
Chloroquine—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000254	0.00238	CcSEcCtD
Chloroquine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000254	0.00237	CcSEcCtD
Chloroquine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000254	0.00237	CcSEcCtD
Chloroquine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000253	0.00236	CcSEcCtD
Chloroquine—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00236	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000251	0.00235	CcSEcCtD
Chloroquine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000251	0.00235	CcSEcCtD
Chloroquine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00025	0.00234	CcSEcCtD
Chloroquine—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.00233	CcSEcCtD
Chloroquine—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00232	CcSEcCtD
Chloroquine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.00232	CcSEcCtD
Chloroquine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.0023	CcSEcCtD
Chloroquine—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000246	0.0104	CbGeAlD
Chloroquine—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.00229	CcSEcCtD
Chloroquine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000245	0.00229	CcSEcCtD
Chloroquine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000244	0.00228	CcSEcCtD
Chloroquine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.00228	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000243	0.00227	CcSEcCtD
Chloroquine—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00227	CcSEcCtD
Chloroquine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000243	0.00227	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000242	0.00227	CcSEcCtD
Chloroquine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.00226	CcSEcCtD
Chloroquine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00024	0.00225	CcSEcCtD
Chloroquine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00224	CcSEcCtD
Chloroquine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.00224	CcSEcCtD
Chloroquine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00024	0.00224	CcSEcCtD
Chloroquine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000239	0.00223	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000239	0.00223	CcSEcCtD
Chloroquine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.00222	CcSEcCtD
Chloroquine—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000236	0.00997	CbGeAlD
Chloroquine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000236	0.00221	CcSEcCtD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—IFNA1—acquired immunodeficiency syndrome	0.000235	0.00954	CbGpPWpGaD
Chloroquine—ABCB1—retina—acquired immunodeficiency syndrome	0.000235	0.0099	CbGeAlD
Chloroquine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000233	0.00982	CbGeAlD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.000233	0.00945	CbGpPWpGaD
Chloroquine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000233	0.00218	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.000232	0.00942	CbGpPWpGaD
Chloroquine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000232	0.00217	CcSEcCtD
Chloroquine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000232	0.00217	CcSEcCtD
Chloroquine—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.00217	CcSEcCtD
Chloroquine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00216	CcSEcCtD
Chloroquine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000231	0.00216	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.00023	0.00935	CbGpPWpGaD
Chloroquine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00023	0.00215	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.00023	0.00932	CbGpPWpGaD
Chloroquine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00215	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.00023	0.00931	CbGpPWpGaD
Chloroquine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000229	0.00967	CbGeAlD
Chloroquine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000229	0.00214	CcSEcCtD
Chloroquine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000228	0.00213	CcSEcCtD
Chloroquine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.00213	CcSEcCtD
Chloroquine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.00212	CcSEcCtD
Chloroquine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000227	0.00212	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.000226	0.00917	CbGpPWpGaD
Chloroquine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000226	0.00211	CcSEcCtD
Chloroquine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000224	0.00209	CcSEcCtD
Chloroquine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000224	0.00209	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—IFNG—acquired immunodeficiency syndrome	0.000224	0.00907	CbGpPWpGaD
Chloroquine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000223	0.00209	CcSEcCtD
Chloroquine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00208	CcSEcCtD
Chloroquine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000223	0.00208	CcSEcCtD
Chloroquine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000222	0.00208	CcSEcCtD
Chloroquine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000222	0.00208	CcSEcCtD
Chloroquine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000222	0.00936	CbGeAlD
Chloroquine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000222	0.00208	CcSEcCtD
Chloroquine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000221	0.00207	CcSEcCtD
Chloroquine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000221	0.00206	CcSEcCtD
Chloroquine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00022	0.00205	CcSEcCtD
Chloroquine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00205	CcSEcCtD
Chloroquine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000219	0.00204	CcSEcCtD
Chloroquine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000218	0.00921	CbGeAlD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000218	0.00882	CbGpPWpGaD
Chloroquine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.00203	CcSEcCtD
Chloroquine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000216	0.00202	CcSEcCtD
Chloroquine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.00202	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—CD4—acquired immunodeficiency syndrome	0.000216	0.00876	CbGpPWpGaD
Chloroquine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.002	CcSEcCtD
Chloroquine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00199	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000213	0.00862	CbGpPWpGaD
Chloroquine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.00198	CcSEcCtD
Chloroquine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000211	0.00197	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000211	0.00197	CcSEcCtD
Chloroquine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.00196	CcSEcCtD
Chloroquine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000209	0.00195	CcSEcCtD
Chloroquine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.00193	CcSEcCtD
Chloroquine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000206	0.00192	CcSEcCtD
Chloroquine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000206	0.00192	CcSEcCtD
Chloroquine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00192	CcSEcCtD
Chloroquine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000205	0.00192	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000205	0.00831	CbGpPWpGaD
Chloroquine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00191	CcSEcCtD
Chloroquine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000204	0.00191	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.000204	0.00827	CbGpPWpGaD
Chloroquine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000203	0.00857	CbGeAlD
Chloroquine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000203	0.00189	CcSEcCtD
Chloroquine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000202	0.00189	CcSEcCtD
Chloroquine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000201	0.00188	CcSEcCtD
Chloroquine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.00188	CcSEcCtD
Chloroquine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000201	0.00188	CcSEcCtD
Chloroquine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.00188	CcSEcCtD
Chloroquine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000199	0.00186	CcSEcCtD
Chloroquine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000199	0.00186	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL2—acquired immunodeficiency syndrome	0.000199	0.00806	CbGpPWpGaD
Chloroquine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000199	0.00186	CcSEcCtD
Chloroquine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000198	0.00186	CcSEcCtD
Chloroquine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000197	0.00184	CcSEcCtD
Chloroquine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00184	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000196	0.00797	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000196	0.00183	CcSEcCtD
Chloroquine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000196	0.00183	CcSEcCtD
Chloroquine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.00183	CcSEcCtD
Chloroquine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00182	CcSEcCtD
Chloroquine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.00181	CcSEcCtD
Chloroquine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.00181	CcSEcCtD
Chloroquine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.00181	CcSEcCtD
Chloroquine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.0018	CcSEcCtD
Chloroquine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.0018	CcSEcCtD
Chloroquine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000192	0.0018	CcSEcCtD
Chloroquine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000192	0.0018	CcSEcCtD
Chloroquine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.00179	CcSEcCtD
Chloroquine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.00179	CcSEcCtD
Chloroquine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00177	CcSEcCtD
Chloroquine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000189	0.00177	CcSEcCtD
Chloroquine—CYP1A1—brain—acquired immunodeficiency syndrome	0.000188	0.00791	CbGeAlD
Chloroquine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000187	0.00175	CcSEcCtD
Chloroquine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.00174	CcSEcCtD
Chloroquine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00174	CcSEcCtD
Chloroquine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.00174	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.00173	CcSEcCtD
Chloroquine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.00173	CcSEcCtD
Chloroquine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000185	0.00173	CcSEcCtD
Chloroquine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00172	CcSEcCtD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—acquired immunodeficiency syndrome	0.000184	0.00746	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.000183	0.00744	CbGpPWpGaD
Chloroquine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000183	0.00171	CcSEcCtD
Chloroquine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000182	0.0017	CcSEcCtD
Chloroquine—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000181	0.00765	CbGeAlD
Chloroquine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00169	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000181	0.00734	CbGpPWpGaD
Chloroquine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.00169	CcSEcCtD
Chloroquine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00018	0.00169	CcSEcCtD
Chloroquine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00018	0.0076	CbGeAlD
Chloroquine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000179	0.00168	CcSEcCtD
Chloroquine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000179	0.00167	CcSEcCtD
Chloroquine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00167	CcSEcCtD
Chloroquine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000178	0.00167	CcSEcCtD
Chloroquine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.00167	CcSEcCtD
Chloroquine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.00166	CcSEcCtD
Chloroquine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000177	0.00748	CbGeAlD
Chloroquine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.00166	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.00166	CcSEcCtD
Chloroquine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000177	0.00166	CcSEcCtD
Chloroquine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.00165	CcSEcCtD
Chloroquine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000176	0.00165	CcSEcCtD
Chloroquine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000176	0.00164	CcSEcCtD
Chloroquine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000176	0.00164	CcSEcCtD
Chloroquine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00164	CcSEcCtD
Chloroquine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.00164	CcSEcCtD
Chloroquine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000174	0.00163	CcSEcCtD
Chloroquine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.00163	CcSEcCtD
Chloroquine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00163	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000174	0.00705	CbGpPWpGaD
Chloroquine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000173	0.00731	CbGeAlD
Chloroquine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000173	0.00162	CcSEcCtD
Chloroquine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000173	0.00162	CcSEcCtD
Chloroquine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.00161	CcSEcCtD
Chloroquine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.0016	CcSEcCtD
Chloroquine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000171	0.0072	CbGeAlD
Chloroquine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.0016	CcSEcCtD
Chloroquine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.00159	CcSEcCtD
Chloroquine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.00159	CcSEcCtD
Chloroquine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.00158	CcSEcCtD
Chloroquine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.00158	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000168	0.00681	CbGpPWpGaD
Chloroquine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000167	0.00156	CcSEcCtD
Chloroquine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00156	CcSEcCtD
Chloroquine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000167	0.00704	CbGeAlD
Chloroquine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000167	0.00156	CcSEcCtD
Chloroquine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.00155	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.000166	0.00673	CbGpPWpGaD
Chloroquine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.00154	CcSEcCtD
Chloroquine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.00154	CcSEcCtD
Chloroquine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000165	0.00695	CbGeAlD
Chloroquine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000164	0.00154	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000164	0.00665	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.00153	CcSEcCtD
Chloroquine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00152	CcSEcCtD
Chloroquine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000163	0.00152	CcSEcCtD
Chloroquine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.00152	CcSEcCtD
Chloroquine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.00152	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000161	0.00655	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—IL10—acquired immunodeficiency syndrome	0.000161	0.00654	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	0.000161	0.00654	CbGpPWpGaD
Chloroquine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000161	0.0015	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.000159	0.00645	CbGpPWpGaD
Chloroquine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.00148	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.00147	CcSEcCtD
Chloroquine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.00147	CcSEcCtD
Chloroquine—ABCB1—blood—acquired immunodeficiency syndrome	0.000157	0.00662	CbGeAlD
Chloroquine—TNF—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.000157	0.00636	CbGpPWpGaD
Chloroquine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.00146	CcSEcCtD
Chloroquine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000155	0.00145	CcSEcCtD
Chloroquine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000155	0.00145	CcSEcCtD
Chloroquine—TNF—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000155	0.00628	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000154	0.00627	CbGpPWpGaD
Chloroquine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.00144	CcSEcCtD
Chloroquine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00144	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000153	0.00622	CbGpPWpGaD
Chloroquine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.00143	CcSEcCtD
Chloroquine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000152	0.00641	CbGeAlD
Chloroquine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.00142	CcSEcCtD
Chloroquine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.00142	CcSEcCtD
Chloroquine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000151	0.00638	CbGeAlD
Chloroquine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.00141	CcSEcCtD
Chloroquine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.00141	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00141	CcSEcCtD
Chloroquine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.0014	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000147	0.00598	CbGpPWpGaD
Chloroquine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.00138	CcSEcCtD
Chloroquine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.00137	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000146	0.00592	CbGpPWpGaD
Chloroquine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000146	0.00614	CbGeAlD
Chloroquine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.00136	CcSEcCtD
Chloroquine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.00136	CcSEcCtD
Chloroquine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.00136	CcSEcCtD
Chloroquine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00135	CcSEcCtD
Chloroquine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000144	0.00135	CcSEcCtD
Chloroquine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00134	CcSEcCtD
Chloroquine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000143	0.00134	CcSEcCtD
Chloroquine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000142	0.00133	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000141	0.00571	CbGpPWpGaD
Chloroquine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.00131	CcSEcCtD
Chloroquine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00129	CcSEcCtD
Chloroquine—ABCB1—lung—acquired immunodeficiency syndrome	0.000138	0.00581	CbGeAlD
Chloroquine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00129	CcSEcCtD
Chloroquine—TNF—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	0.000138	0.00558	CbGpPWpGaD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000137	0.00557	CbGpPWpGaD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000137	0.00554	CbGpPWpGaD
Chloroquine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.00127	CcSEcCtD
Chloroquine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.00127	CcSEcCtD
Chloroquine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000136	0.00571	CbGeAlD
Chloroquine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.00126	CcSEcCtD
Chloroquine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00126	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000134	0.00545	CbGpPWpGaD
Chloroquine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.00126	CcSEcCtD
Chloroquine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.00126	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000132	0.00535	CbGpPWpGaD
Chloroquine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00123	CcSEcCtD
Chloroquine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.00122	CcSEcCtD
Chloroquine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00121	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.00013	0.00526	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.00013	0.00526	CbGpPWpGaD
Chloroquine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.00121	CcSEcCtD
Chloroquine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.00121	CcSEcCtD
Chloroquine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.0012	CcSEcCtD
Chloroquine—TNF—TGF-beta Receptor Signaling—IFNG—acquired immunodeficiency syndrome	0.000128	0.00521	CbGpPWpGaD
Chloroquine—TLR9—IRS-mediated signalling—IL6—acquired immunodeficiency syndrome	0.000128	0.0052	CbGpPWpGaD
Chloroquine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000128	0.00538	CbGeAlD
Chloroquine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.00119	CcSEcCtD
Chloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	0.000127	0.00515	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000127	0.00513	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000126	0.0051	CbGpPWpGaD
Chloroquine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00117	CcSEcCtD
Chloroquine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00117	CcSEcCtD
Chloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	0.000125	0.00506	CbGpPWpGaD
Chloroquine—TLR9—IRS-related events—IL6—acquired immunodeficiency syndrome	0.000125	0.00506	CbGpPWpGaD
Chloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	0.000124	0.00501	CbGpPWpGaD
Chloroquine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.00115	CcSEcCtD
Chloroquine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000123	0.00518	CbGeAlD
Chloroquine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.00114	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000121	0.00492	CbGpPWpGaD
Chloroquine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00113	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.00012	0.00488	CbGpPWpGaD
Chloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	0.00012	0.00488	CbGpPWpGaD
Chloroquine—TLR9—Insulin receptor signalling cascade—IL6—acquired immunodeficiency syndrome	0.00012	0.00488	CbGpPWpGaD
Chloroquine—TLR9—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	0.00012	0.00488	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00012	0.00486	CbGpPWpGaD
Chloroquine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.00112	CcSEcCtD
Chloroquine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00111	CcSEcCtD
Chloroquine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.00111	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL6—acquired immunodeficiency syndrome	0.000117	0.00474	CbGpPWpGaD
Chloroquine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.00109	CcSEcCtD
Chloroquine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.00108	CcSEcCtD
Chloroquine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.00107	CcSEcCtD
Chloroquine—TLR9—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000114	0.00464	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000114	0.00462	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000114	0.00461	CbGpPWpGaD
Chloroquine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.00105	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000111	0.00449	CbGpPWpGaD
Chloroquine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.00104	CcSEcCtD
Chloroquine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.00103	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000109	0.00444	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—acquired immunodeficiency syndrome	0.000109	0.00444	CbGpPWpGaD
Chloroquine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00102	CcSEcCtD
Chloroquine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00101	CcSEcCtD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000108	0.00437	CbGpPWpGaD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000108	0.00437	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	0.000107	0.00435	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000107	0.00434	CbGpPWpGaD
Chloroquine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000968	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000103	0.00418	CbGpPWpGaD
Chloroquine—TNF—amb2 Integrin signaling—IL6—acquired immunodeficiency syndrome	0.000102	0.00414	CbGpPWpGaD
Chloroquine—TLR9—Signaling by Insulin receptor—IL6—acquired immunodeficiency syndrome	9.99e-05	0.00405	CbGpPWpGaD
Chloroquine—ABCB1—brain—acquired immunodeficiency syndrome	9.75e-05	0.00411	CbGeAlD
Chloroquine—TNF—Folate Metabolism—IL2—acquired immunodeficiency syndrome	9.72e-05	0.00394	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—IL2—acquired immunodeficiency syndrome	9.72e-05	0.00394	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	9.52e-05	0.00386	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	9.47e-05	0.00384	CbGpPWpGaD
Chloroquine—ABCB1—lymph node—acquired immunodeficiency syndrome	9.42e-05	0.00397	CbGeAlD
Chloroquine—TLR9—Immune System—MBL2—acquired immunodeficiency syndrome	9.4e-05	0.00381	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	9.35e-05	0.00379	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	9.32e-05	0.00378	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	9.08e-05	0.00368	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	8.69e-05	0.00353	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	8.65e-05	0.00351	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	8.58e-05	0.00348	CbGpPWpGaD
Chloroquine—TLR9—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	8.55e-05	0.00347	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.53e-05	0.00346	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.53e-05	0.00346	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—IL2—acquired immunodeficiency syndrome	8.42e-05	0.00342	CbGpPWpGaD
Chloroquine—TNF—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	8.2e-05	0.00333	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	8.1e-05	0.00328	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	8.01e-05	0.00325	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.71e-05	0.00313	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CCR2—acquired immunodeficiency syndrome	7.37e-05	0.00299	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	7.12e-05	0.00289	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	7.06e-05	0.00287	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	7.06e-05	0.00287	CbGpPWpGaD
Chloroquine—TNF—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	7.02e-05	0.00285	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	6.87e-05	0.00279	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	6.87e-05	0.00279	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	6.72e-05	0.00273	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IFNA1—acquired immunodeficiency syndrome	6.64e-05	0.00269	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD79A—acquired immunodeficiency syndrome	6.44e-05	0.00261	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	6.11e-05	0.00248	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.73e-05	0.00232	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—IL6—acquired immunodeficiency syndrome	5.71e-05	0.00232	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.27e-05	0.00214	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD40LG—acquired immunodeficiency syndrome	5.25e-05	0.00213	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.25e-05	0.00213	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD8A—acquired immunodeficiency syndrome	5.19e-05	0.00211	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CSF2—acquired immunodeficiency syndrome	5.19e-05	0.00211	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	5.19e-05	0.0021	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	5.19e-05	0.0021	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CD4—acquired immunodeficiency syndrome	5.12e-05	0.00208	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-B—acquired immunodeficiency syndrome	5e-05	0.00203	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.77e-05	0.00193	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	4.54e-05	0.00184	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.48e-05	0.00182	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.48e-05	0.00182	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.38e-05	0.00178	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.15e-05	0.00168	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.03e-05	0.00164	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.69e-05	0.0015	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.59e-05	0.00146	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.41e-05	0.00138	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.36e-05	0.00136	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—IL6—acquired immunodeficiency syndrome	3.32e-05	0.00135	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	3.17e-05	0.00129	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	3.15e-05	0.00128	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IFNG—acquired immunodeficiency syndrome	3.09e-05	0.00125	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.07e-05	0.00125	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	3e-05	0.00122	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD4—acquired immunodeficiency syndrome	2.98e-05	0.00121	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.87e-05	0.00116	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.77e-05	0.00112	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	2.75e-05	0.00112	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL2—acquired immunodeficiency syndrome	2.74e-05	0.00111	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	2.7e-05	0.00109	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.69e-05	0.00109	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.55e-05	0.00103	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.4e-05	0.000972	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	2.34e-05	0.000948	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.26e-05	0.000916	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—ALB—acquired immunodeficiency syndrome	2.19e-05	0.00089	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.04e-05	0.000826	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.92e-05	0.000779	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.77e-05	0.00072	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000654	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.48e-05	0.000599	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.33e-05	0.000538	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.25e-05	0.000509	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.17e-05	0.000476	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000463	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.08e-05	0.000437	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000423	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.92e-06	0.000362	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	5.54e-06	0.000225	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.23e-06	0.000212	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	4.79e-06	0.000195	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.18e-06	0.000169	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.94e-06	0.00016	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.57e-06	0.000104	CbGpPWpGaD
